CSIMarket


Bioventus Inc   (BVS)
Other Ticker:  
 

Bioventus Inc

BVS's Fundamental analysis








Looking into Bioventus Inc growth rates, revenue grew in IV. Quarter 2023 from the same quarter a year ago. Ranking at No. 291

Medical Equipment & Supplies industry recorded growth of revenues by 10.07 %

Bioventus Inc net loss deacreased by in IV. Quarter 2023 year on year, Bioventus Inc net loss increased by -96.91 % in IV. Quarter 2023 year on year,

More on BVS's Growth


Bioventus Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 56.78 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.57.
Medical Equipment & Supplies industry's Price to Sales ratio is at 3.91.


More on BVS's Valuation
 
 Total Debt (Millions $) 395
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 4.32
 Tangible Book Value (Per Share $) -4.28

Bioventus Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 56.78 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.57.
Medical Equipment & Supplies industry's Price to Sales ratio is at 3.91.

Bioventus Inc Price to Book Ratio is at 1.32 higher than Indusry Avg. of -482.4, and higher than S&P 500 Avg. of 0.01

More on BVS's Valuation

  Market Capitalization (Millions $) 291
  Shares Outstanding (Millions) 63
  Employees -
  Revenues (TTM) (Millions $) 512
  Net Income (TTM) (Millions $) -196
  Cash Flow (TTM) (Millions $) 5
  Capital Exp. (TTM) (Millions $) -7
  Total Debt (Millions $) 395
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 4.32
  Tangible Book Value (Per Share $) -4.28

  Market Capitalization (Millions $) 291
  Shares Outstanding (Millions) 63
  Employees -
  Revenues (TTM) (Millions $) 512
  Net Income (TTM) (Millions $) -196
  Cash Flow (TTM) (Millions $) 5
  Capital Exp. (TTM) (Millions $) -7


    BVS's Profitability Comparisons
Bioventus Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in IV. Quarter 2023 to 0.85 % from 2.02 % in III. Quarter.







  Ratio
   Capital Ratio (MRQ) 1.53
  Total Debt to Equity (MRQ) 1.79
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.62
  Inventory Turnover Ratio (TTM) 1.97



Bioventus Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in IV. Quarter 2023 to 0.85 % from 2.02 % in III. Quarter.



More on BVS's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com